Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Alliance Grants

University of Victoria

$25,000.00

An injectable hydrogel for co-delivery of immunotherapy and chemotherapy drugs

FY 2022-23

Summary
Delivering drugs directly to the site of a tumor is attractive because it reduces systemic toxicities and allows for delivering higher doses of drugs at the tumor site. This project aims to develop a drug-eluting shear-thinning material capable of delivering multiple drugs to a tumor using minimally-invasive surgeries. We have recently developed a nanocomposite hydrogel composed of gelatin and a synthetic nanoclay that is biodegradable and biocompatible. The proposed hydrogel undergoes a reversible reduction in viscosity upon exposure to high shear stresses; thereby, it can be injected through medical catheters or surgical needles with a minimum required force. To deliver this material, we will utilize our patent-pending hand-held injection device that enables the precise delivery of hydrogels. In this project, we will collaborate with our partner at MIT to load immunotherapy agents onto the hydrogel and determine optimum drug dosages and release profiles that maximize the therapeutic outcomes of the drugs. To achieve this goal, a fourth-year Ph.D. student will be sent to our international collaborator's lab to gain hands-on experience in molecular cell bioengineering techniques and to use them in a scientific-class application. This project helps the trainee develop research skills such as quantitative experimental assays, patient-derived cell culture methodology, and cancer immunotherapy, which are required to achieve the goals of this proposal.
Program
Alliance Grants
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
576519-2022
Name nom
Akbari, Mohsen M
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Installment
inst:1
Partie
1
Nb partie
1
Application title
An injectable hydrogel for co-delivery of immunotherapy and chemotherapy drugs
Application summary
Delivering drugs directly to the site of a tumor is attractive because it reduces systemic toxicities and allows for delivering higher doses of drugs at the tumor site. This project aims to develop a drug-eluting shear-thinning material capable of delivering multiple drugs to a tumor using minimally-invasive surgeries. We have recently developed a nanocomposite hydrogel composed of gelatin and a synthetic nanoclay that is biodegradable and biocompatible. The proposed hydrogel undergoes a reversible reduction in viscosity upon exposure to high shear stresses; thereby, it can be injected through medical catheters or surgical needles with a minimum required force. To deliver this material, we will utilize our patent-pending hand-held injection device that enables the precise delivery of hydrogels. In this project, we will collaborate with our partner at MIT to load immunotherapy agents onto the hydrogel and determine optimum drug dosages and release profiles that maximize the therapeutic outcomes of the drugs. To achieve this goal, a fourth-year Ph.D. student will be sent to our international collaborator's lab to gain hands-on experience in molecular cell bioengineering techniques and to use them in a scientific-class application. This project helps the trainee develop research skills such as quantitative experimental assays, patient-derived cell culture methodology, and cancer immunotherapy, which are required to achieve the goals of this proposal.